Abstract:
1,1,3,3-Tetrafluoropropan-2-ol and 1,1,1,3,3-pentafluoropropan2-ol are prepared by the vapor phase catalytic halogen hydrogenolysis and carbonyl reduction of perhaloacetones with hydrogen employing a supported palladium on carbon catalyst.
Abstract:
1,159,000. Inhalation anaesthetics. BAXTER LABORATORIES Inc. 1 March, 1967 [23 March, 19661, No. 9591/67. Heading A5B [Also in Division C2] Inhalation anaesthetic compositions comprise the compound in admixture with oxygen in suitable proportions for the production of anaesthetic and capable of supporting respiration. Other materials which may be present in the compositions are stabilisers, e.g. thymol, and known inhalation anaesthetics, e.g. nitrous oxide, ether, chloroiforim, halothane, cyclopropane and imethoxyflurane. The oxygen may be provided in the form of oxygen itself, air, or other gaseous mixtures containing oxygen.
Abstract:
1,159,000. Inhalation anaesthetics. BAXTER LABORATORIES Inc. 1 March, 1967 [23 March, 19661, No. 9591/67. Heading A5B [Also in Division C2] Inhalation anaesthetic compositions comprise the compound in admixture with oxygen in suitable proportions for the production of anaesthetic and capable of supporting respiration. Other materials which may be present in the compositions are stabilisers, e.g. thymol, and known inhalation anaesthetics, e.g. nitrous oxide, ether, chloroiforim, halothane, cyclopropane and imethoxyflurane. The oxygen may be provided in the form of oxygen itself, air, or other gaseous mixtures containing oxygen.